WORKING DAYS
Mon-Sat: 10.00 to 7.00
Impact of New GST Reforms on the Ophthalmic Pharma Industry in India – The Ophthalmic Pharma industry has been flourishing at this time. The protected growth rate for ophthalmic products is around 38.20 billion dollars in 2024 and is expected to reach 62.08 billion dollars by 2030 globally. These numbers are proof of the demand for ophthalmic products. Thus, many entrepreneurs and manufacturers started seeking business opportunities in this segment.
In September 2025, the Indian Government introduced new GST reforms to revolutionize the healthcare industry. This impact caused various challenges and advantages in the ophthalmic industry. Leading Companies like Eyeris Vision Care have been a major contributor in the industry for many years. With a proper vision and understanding of these reforms, they have incorporated a few changes in their strategy. To learn more about the Impact of the New GST Reforms on the Ophthalmic Pharma Industry in India, read this blog till the end.
The new GST reforms have had a significant impact on the ophthalmic pharmaceutical industry. The government exempted 36 drugs from GST. Also, the rate of the rest of the medicines has been reduced to 5% so that every patient has access to the therapies. This helped reduce the cost of various medications for severe diseases, such as cancer. Earlier, there were 4 slabs in GST: 0%, 5%, 12% and 18%. But, now this has been changed to 5% and 18%, which avoids confusion while calculating the bill. The distribution of these taxes is as follows:
5% – Corrective Spectacles/ frames/ reading glasses/lenses, contact lenses, optical equipment used in ophthalmology, ophthalmic medicines, eye drops
18% – Non-medical sunglasses, cosmetic eye care, non-prescription fashion eyewear.
This distribution helped in reducing the GST on life-saving goods. The 18% GST has been kept on the medicines that are not in much need, such as supplements and other OTC products. This impact helped various healthcare institutes, hospitals, and clinics in reducing the cost of medicines. When it comes to manufacturers in the pharma industry, it has caused challenges and various benefits. They experienced a huge demand for life-saving medications as the prices were cut down. But the stock, which they had earlier needed to be branded again, with the new costs which created confusion.
When searching for a leading ophthalmic product company, the name of Eyeris Vision Care comes at the top. The company has been contributing with a wide range of products in the healthcare sector. It is backed by a team of professionals who have a great experience in the pharma industry. For many years, they have been dealing in eye products in various forms such as tablets, capsules, eye drops, powder, and gummies.
Eyeris Vision Care has always adhered to the GST reforms and have kept prices of their products accordingly. As the GST rules have been reformed now, they took it as an advantage to scale their business and helped various people seeking business opportunities. Not only that, they have been the ultimate choice of doctors from leading hospitals. Some of the points that separate them from others are:
Thus, by associating with them, not only do you adhere to the GST reforms but also get to learn from the best in the industry. Many associates have benefited from their collaboration, and you can be one of them!
We hope that after reading the above blog, you are aware of the new GST reforms and their impact on the Ophthalmic pharma industry. So, if you want to grow your career in this segment, then this is the right time. By getting the necessary support and mentorship from a monopoly-based company like Eyeris Vision Care, you can easily scale your business in no time. If you are interested in collaborating with them, then you can reach out at: 91-9034803607 || eyerisvisioncare@gmail.com.
